前列腺癌患者治疗前血清非蛋白结合皮质醇和总17-羟皮质类固醇值与生存率的相关性 - Suppr | 超能文献

Correlation of pretreatment serum nonprotein-bound cortisol and total 17-hydroxycorticosteroid values with survival in patients with prostatic cancer.

作者信息

Blackard C E, Byar D P, Seal U S, Doe R P

出版信息

N Engl J Med. 1974 Oct 10;291(15):751-5. doi: 10.1056/NEJM197410102911502.

DOI:10.1056/NEJM197410102911502

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Correlation of pretreatment serum nonprotein-bound cortisol and total 17-hydroxycorticosteroid values with survival in patients with prostatic cancer.前列腺癌患者治疗前血清非蛋白结合皮质醇和总17-羟皮质类固醇值与生存率的相关性

N Engl J Med. 1974 Oct 10;291(15):751-5. doi: 10.1056/NEJM197410102911502.

2

Serum corticosteroid-binding globulin, cortisol, and nonprotein-bound cortisol levels in patients receiving estrogen for carcinoma of the prostate.接受雌激素治疗前列腺癌患者的血清皮质类固醇结合球蛋白、皮质醇及非蛋白结合皮质醇水平

Invest Urol. 1973 Nov;11(3):194-7.

3

Endocrine treatment of cancer of the prostate.前列腺癌的内分泌治疗

Wis Med J. 1970 Jul;69(7):177-81.

4

Response of serum cholesterol and triglycerides to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.血清胆固醇和甘油三酯对激素治疗的反应以及前列腺癌患者治疗前数值与死亡率的关系。

Cancer. 1976 Sep;38(3):1095-107. doi: 10.1002/1097-0142(197609)38:3<1095::aid-cncr2820380309>3.0.co;2-z.

5

Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.血浆纤维蛋白原和纤溶酶原对激素治疗的反应以及前列腺癌患者治疗前数值与死亡率的关系。

Cancer. 1976 Sep;38(3):1108-17. doi: 10.1002/1097-0142(197609)38:3<1108::aid-cncr2820380310>3.0.co;2-l.

6

Correlation of pre-treatment serum 17-hydroxycorticosteroid values with survival in patients with prostatic cancer.

J Urol. 1975 Apr;113(4):517-20. doi: 10.1016/s0022-5347(17)59515-4.

7

Cancer of the prostate.前列腺癌

N Engl J Med. 1968 Apr 11;278(15):848-9. doi: 10.1056/NEJM196804112781512.

8

Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group.

Surg Gynecol Obstet. 1967 May;124(5):1011-7.

9

Response of serum haptoglobin to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.

Cancer. 1978 Oct;42(4):1720-9. doi: 10.1002/1097-0142(197810)42:4<1720::aid-cncr2820420410>3.0.co;2-o.

10

[Hormone therapy of cancer of the prostate gland].[前列腺癌的激素治疗]

Urol Nefrol (Mosk). 1970 May-Jun;35(3):25-8.

引用本文的文献

1

The choice of estrogen preparations in the treatment of prostatic cancer.治疗前列腺癌时雌激素制剂的选择。

Can Med Assoc J. 1975 Nov 8;113(9):865-7.

2

Therapeutic and prognostic aspects of cancer of the prostate detected incidentally in the course of adenoma enucleation.在前列腺腺瘤剜除术过程中偶然发现的前列腺癌的治疗和预后方面。

Int Urol Nephrol. 1978;10(1):23-8. doi: 10.1007/BF02082789.